TCRT Alaunos Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 14, 2026
$0,82
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,8252 haftanın en düşüğü
$4,5952 haftanın en yükseği
Piyasa Değeri (MRQ)
$2M
P/E (TTM)
-0.4
Hisse Başına Kâr (TTM)
$-1.90
Gelir (TTM)
$3.0K
rozetleriniz
52 Haftlık Aralık
$1–$5
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
·
P/E
-0.4
ROE
-185.9%
Net Kâr Marjı
-133666.7%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
TCRT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.82
Piyasa Değeri (MRQ)
$2M
P/E (TTM)
-0.4
Hisse Başına Kâr (TTM)
$-1.90
Gelir (TTM)
$3.0K
ROE (TTM)
-185.9%
52 Haftlık Aralık
$1–$5
TCRT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 18 Temmuz 2024 | 1-for-10 | Ters |
| 01 Şubat 2024 | 1-for-15 | Ters |
Alaunos Therapeutics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
sektörHealthcare
endüstriBiotechnology
çalışanlar1
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$5.0K2017-12-31 → 2025-12-31
Hisse Başına Kâr$-2.202016-12-31 → 2025-12-31
Serbest Nakit Akışı·2016-12-31 → 2023-12-31
Net kar marjı-133666.7%2021-12-31 → 2023-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | TCRT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -0.45Y ort. ≈-96.4 | ≈-96.4 | · | · | |
| F/S (TTM) | 679.55Y ort. ≈43478.1 | ≈43478.1 | · | · | |
| F/D (MRQ) | 3.15Y ort. ≈414.4 | ≈414.4 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 3.55Y ort. ≈249.7 | ≈249.7 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | TCRT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -135266.7%5Y ort. ≈-235342.0% | ≈-235342.0% | · | · | |
| Net Kâr Marjı (TTM) | -133666.7%5Y ort. ≈-241292.6% | ≈-241292.6% | · | · | |
| ROA (TTM) | -128.3%5Y ort. ≈-69.5% | ≈-69.5% | · | · | |
| ROE (TTM) | -185.9%5Y ort. ≈-192.9% | ≈-192.9% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | TCRT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 0.85Y ort. ≈3.8 | ≈3.8 | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | TCRT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -50.0%5Y ort. ≈146.1% | ≈146.1% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -88.0% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | TCRT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue / Employee (Çalışan Başına Gelir) | ≈$5.0K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.51%
Sonraki Rapor
Kas 12, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 31 Aralık 2023 | $-4.90 | $-4.59 | -6.8% | |
| 30 Eylül 2023 | $-6.00 | $-5.36 | -12.0% | |
| 30 Haziran 2023 | $-6.00 | $-6.73 | 10.9% | |
| 31 Mart 2023 | $-6.00 | $-6.38 | 5.9% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.0K | $10.0K | $5.0K | $3M | $398.0K | $0 | · | $146.0K | $16M | · | · | · | |
| R&D Expense | $1M | $362.0K | $16M | $25M | $50M | $53M | $38M | $34M | $45M | $158M | $107M | $33M | |
| SG&A Expense | $3M | $4M | $12M | $13M | $28M | $28M | $20M | $20M | $15M | $14M | $18M | $12M | |
| Operating Expenses | $4M | $5M | $34M | $38M | $78M | $80M | $58M | $54M | $60M | · | · | · | |
| Operating Income | $-4M | $-5M | $-34M | $-35M | $-78M | $-80M | $-58M | $-54M | $-53M | $-165M | $-120M | $-43M | |
| Interest Expense | · | · | $2M | $3M | $1M | · | · | · | · | · | · | · | |
| Other Non-op | $80.0K | $133.0K | $1M | $529.0K | $-13.0K | $385.0K | $813.0K | $631.0K | $465.0K | $134.0K | $12.0K | $-5.0K | |
| Income Tax | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-4M | $-5M | $-5M | $-38M | $-79M | $-80M | $-118M | $-53M | $-54M | $-165M | $-120M | $-32M | |
| EPS (Basic) | $-2.20 | $-2.92 | $-21.97 | $-2.61 | $-0.37 | $-0.38 | $-0.70 | $0.96 | $-0.53 | $-1.32 | · | · | |
| EPS (Diluted) | $-2.20 | $-2.92 | $-21.97 | $-2.61 | $-0.37 | $-0.38 | $-0.70 | $0.96 | $-0.53 | $-1.32 | · | · | |
| Shares (Basic) | 1,948,357 | 1,601,252 | 1,599,532 | 14,475,354 | 214,399,074 | 209,636,456 | 167,952,114 | 143,508,674 | 136,938,264 | 130,391,463 | · | · | |
| Shares (Diluted) | 1,948,357 | 1,601,252 | 1,599,532 | 14,475,354 | 214,399,074 | 209,636,456 | 167,952,114 | 143,710,160 | 136,938,264 | 130,391,463 | · | · | |
| EBITDA | · | · | $-34M | $-35M | $-78M | $-80M | · | $-54M | · | $-165M | $-120M | $-43M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $1M | $6M | $39M | $76M | $115M | $80M | $62M | $71M | $81M | $141M | $43M | |
| Receivables | $3.0K | $5.0K | $1.0K | $4.0K | $1M | $5M | $3M | $2M | $19.0K | $21.0K | $446.0K | $145.0K | |
| Prepaid Expense | $600.0K | $2M | $2M | $799.0K | $2M | $11M | $22M | $21M | $20M | $24M | $11M | $1M | |
| Current Assets | $2M | $3M | $8M | $54M | $79M | $131M | $105M | $84M | $91M | $105M | $153M | $44M | |
| PP&E (Net) | $91.0K | $0 | $2.0K | $8M | $11M | $10M | $1M | $1M | $1M | $843.0K | $581.0K | $531.0K | |
| PP&E (Gross) | $98.0K | $15.0K | $15.0K | $18M | $18M | $15M | $6M | $5M | $5M | $4M | $4M | $3M | |
| Accum. Depreciation | $7.0K | $15.0K | $13.0K | $10M | $7M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | |
| Other Non-current Assets | · | · | $0 | $500.0K | $631.0K | $745.0K | $110.0K | $10M | $13M | $493.0K | $494.0K | $491.0K | |
| Total Assets | $3M | $3M | $8M | $65M | $95M | $146M | $109M | $95M | $106M | $106M | $154M | $45M | |
| Accounts Payable | $613.0K | $516.0K | $616.0K | $1M | $1M | $960.0K | $906.0K | $707.0K | $4M | $156.0K | $2M | $2M | |
| Accrued Liabilities | $200.0K | $176.0K | $1M | $5M | $6M | $17M | $11M | $9M | $10M | $9M | $9M | $7M | |
| Current Liabilities | $813.0K | $692.0K | $2M | $24M | $16M | $18M | $13M | $9M | $21M | $16M | $18M | $11M | |
| Capital Leases | · | · | · | · | · | $4M | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | $0 | $28.0K | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $813.0K | $692.0K | $2M | $26M | $37M | $22M | $14M | $9M | $58M | $58M | $66M | $11M | |
| Long-term Debt | · | · | $0 | $17M | $24M | $0 | · | · | · | · | · | · | |
| Total Debt | · | · | $0 | $17M | $24M | · | · | · | · | · | · | · | |
| Common Stock | $2.0K | $2.0K | $2.0K | $16.0K | $216.0K | $215.0K | $182.0K | $161.0K | $143.0K | $132.0K | $132.0K | $104.0K | |
| Retained Earnings | $-925M | $-920M | $-916M | $-881M | $-843M | $-764M | $-684M | $-566M | $-712M | $-658M | $-493M | $-373M | |
| Stockholders' Equity | $2M | $2M | $6M | $39M | $58M | $124M | $95M | $86M | $-97M | $-77M | $87M | $34M | |
| Liabilities + Equity | $3M | $3M | $8M | $65M | $95M | $146M | $109M | $95M | $106M | $106M | $154M | $45M | |
| Shares Outstanding | 2,349,480 | 1,601,252 | 1,601,252 | 16,027,384 | 216,127,443 | 214,591,906 | 181,803,320 | 161,066,136 | 142,658,037 | 132,376,670 | 131,718,579 | 104,452,105 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $290.0K | $357.0K | $462.0K | |
| Stock-based Comp | $796.0K | $435.0K | $3M | $4M | $11M | $7M | $6M | $8M | $8M | $8M | $8M | $5M | |
| Restructuring | · | $0 | $1M | $0 | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-5M | $-30M | $-29M | $-61M | $-57M | $-41M | $-49M | $-55M | $-58M | $-10.0K | $-37M | |
| CapEx | $98.0K | $0 | $197.0K | $216.0K | $3M | $10M | $284.0K | $459.0K | $737.0K | $551.0K | $412.0K | $193.0K | |
| Investing Cash Flow | $-98.0K | $0 | $1M | $-193.0K | $-3M | $-10M | $-284.0K | $-459.0K | $-737.0K | $-551.0K | · | · | |
| Debt Issued | · | · | · | $0 | $25M | $0 | · | · | · | · | · | · | |
| Net Debt Issued | · | · | $-18M | $-8M | $25M | · | · | · | · | · | · | · | |
| Stock Issued | · | $0 | $92.0K | $15M | $0 | · | · | · | $47M | · | $94M | · | |
| Stock Repurchased | · | · | $0 | $45.0K | $0 | · | $653.0K | $2M | $0 | $2.0K | $34.0K | $544.0K | |
| Net Stock Activity | · | · | $92.0K | $15M | · | · | · | $-2M | · | $-2.0K | $94M | $-544.0K | |
| Financing Cash Flow | $3M | $0 | $-18M | $6M | $26M | $102M | $59M | $40M | $45M | $-788.0K | · | · | |
| Net Change in Cash | $294.0K | $-5M | $-47M | $-23M | $-39M | $35M | $18M | $-10M | $-10M | $-60M | $98M | $-25M | |
| Taxes Paid | · | · | · | · | · | · | · | $0 | $0 | $0 | · | · | |
| Free Cash Flow | · | · | $-30M | $-29M | $-65M | $-67M | · | $-50M | · | $-59M | $-422.0K | $-37M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -685340.0% | -1201.4% | -19484.7% | · | · | · | · | · | · | · | |
| Net Margin | · | · | -702800.0% | -1291.2% | -19786.7% | · | · | · | · | · | · | · | |
| EBITDA Margin | · | · | -685340.0% | -1201.4% | -19484.7% | · | · | · | · | · | · | · | |
| ROA | · | · | -96.0% | -47.2% | -65.3% | -62.6% | · | -52.9% | · | -127.1% | -120.7% | -54.3% | |
| ROE | · | · | -347.8% | -106.8% | -124.2% | -59.5% | · | 149.9% | · | -3282.0% | -198.2% | -76.4% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 4.2 | 2.2 | 4.9 | 7.1 | · | 8.9 | · | 6.6 | 8.4 | 4.1 | |
| Quick Ratio | · | · | 3.1 | 1.6 | 4.8 | 6.5 | · | 6.7 | · | 5.1 | 7.8 | 4.0 | |
| Debt / Equity | · | · | 0.0 | 0.4 | 0.4 | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | 0.0 | 0.0 | 0.3 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | -17.8 | -11.1 | · | · | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | · | · | 2.0 | 5.2 | 0.1 | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | $0.39 | $0.16 | $0.27 | $0.58 | · | $0.53 | · | $-0.58 | $0.66 | $0.32 | |
| Revenue / Share | · | · | $0.00 | $0.01 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | · | $-1.88 | $-0.13 | · | $-0.27 | · | $-0.34 | · | · | · | · | |
| Cash / Share | · | · | $0.38 | $0.16 | $0.35 | $0.54 | · | $0.38 | · | $0.61 | $1.07 | $0.41 | |
| EPS (TTM) | $-2.20 | $-2.92 | $-21.97 | $-2.61 | $-0.37 | $-0.38 | $-0.70 | $0.96 | $-0.53 | $-1.32 | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -50.0% | 100.0% | -99.8% | 634.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -88.0% | -70.7% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.0K | $10.0K | $5.0K | $3M | $398.0K | $0 | · | $146.0K | $16M | $800.0K | $800.0K | $800.0K | |
| Net Income TTM | $-4M | $-5M | $-5M | $-38M | $-79M | $-80M | $-118M | $-53M | $-54M | $-165M | $-120M | $-32M | |
| Market Cap | · | · | $168M | $23.44B | $35.34B | $81.12B | · | $45.18B | · | $106.23B | $164.19B | $79.44B | |
| Enterprise Value | · | · | $162M | $23.42B | $35.28B | · | · | · | · | · | · | · | |
| P/E | -1.5 | -0.7 | -0.5 | -37.4 | -441.9 | -994.7 | -1011.4 | 292.2 | -1171.7 | -608.0 | · | · | |
| P/S | · | · | 33626.3 | 8021.9 | 88786.0 | · | · | 309445.6 | · | 132790.3 | 205234.0 | 99294.8 | |
| P/B | · | · | 26.7 | 608.0 | 608.7 | 654.3 | · | 528.0 | · | -1374.3 | 1879.2 | 2347.3 | |
| P / Tangible Book | 3.5 | 1.5 | 26.7 | 608.0 | 608.7 | 654.3 | · | · | · | · | · | · | |
| P / Cash Flow | · | · | -5.6 | -801.9 | -574.9 | -1422.8 | · | -913.5 | · | -1821.4 | -16418720.9 | -2167.4 | |
| P / FCF | · | · | -5.5 | -796.0 | -545.4 | -1214.5 | · | -905.1 | · | -1804.3 | -389069.2 | -2156.1 | |
| EV / EBITDA | · | · | -4.7 | -667.1 | -455.0 | · | · | · | · | · | · | · | |
| EV / FCF | · | · | -5.3 | -795.2 | -544.6 | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | 32413.9 | 8014.3 | 88655.5 | · | · | · | · | · | · | · | |
| Earnings Yield | -68.1% | -152.9% | -209.2% | -2.7% | -0.23% | -0.10% | -0.10% | 0.34% | -0.09% | -0.16% | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $3.0K | $0 | $0 | $2.0K | $5.0K | $0 | $4.0K | $1.0K | $0 | $4.0K | $0 | $11.0K | $3M | $0 | |
| R&D Expense | $388.0K | $427.0K | $362.0K | $469.0K | $185.0K | $347.0K | $-87.0K | $143.0K | $180.0K | $126.0K | $4M | $5M | $7M | $6M | $8M | $6M | |
| SG&A Expense | $564.0K | $585.0K | $548.0K | $718.0K | $854.0K | $747.0K | $846.0K | $1M | $990.0K | $2M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $952.0K | $1M | $910.0K | $1M | $1M | $1M | $759.0K | $1M | $1M | $2M | $9M | $8M | $10M | $9M | $11M | $9M | |
| Operating Income | $-952.0K | $-1M | $-907.0K | $-1M | $-1M | $-1M | $-754.0K | $-1M | $-1M | $-2M | $-9M | $-8M | $-10M | $-9M | $-8M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $1M | $853.0K | $890.0K | $841.0K | $740.0K | |
| Other Non-op | $0 | $6.0K | $14.0K | $28.0K | $19.0K | $19.0K | $13.0K | $23.0K | $37.0K | $60.0K | $188.0K | $277.0K | $477.0K | $254.0K | $254.0K | $41.0K | |
| Net Income | $-952.0K | $-1M | $-893.0K | $-1M | $-1M | $-1M | $-741.0K | $-1M | $-1M | $-2M | $-8M | $-9M | $-10M | $-9M | $-9M | $-10M | |
| EPS (Basic) | $-0.41 | $-0.59 | $-0.35 | $-0.55 | $-0.63 | $-0.67 | $-0.46 | $-0.70 | $-0.71 | $-1.05 | $-5.30 | $-5.49 | $-0.63 | $-2.47 | $-0.04 | $-0.05 | |
| EPS (Diluted) | $-0.41 | $-0.59 | $-0.35 | $-0.55 | $-0.63 | $-0.67 | $-0.46 | $-0.70 | $-0.71 | $-1.05 | $-5.30 | $-5.49 | $-0.63 | $-2.47 | $-0.04 | $-0.05 | |
| Shares (Basic) | 2,431,695 | 1,948,357 | · | 2,183,039 | 1,676,345 | 1,601,252 | · | 1,601,252 | 1,600,306 | 1,601,252 | 1,600,306 | 1,598,650 | 15,978,623 | · | 215,098,995 | 214,998,893 | |
| Shares (Diluted) | 2,431,695 | 1,948,357 | · | 2,183,039 | 1,676,345 | 1,601,252 | · | 1,601,252 | 1,600,306 | 1,601,252 | 1,600,306 | 1,598,650 | 15,978,623 | · | 215,098,995 | 214,998,893 | |
| EBITDA | $-952.0K | $-1M | · | $-1M | $-1M | $-1M | · | $-1M | $-1M | $-2M | $-9M | $-8M | $-10M | · | $-8M | $-9M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $124.0K | $354.0K | $1M | $2M | $3M | $319.0K | $1M | $2M | $2M | $4M | $12M | $18M | $23M | $39M | $38M | $60M | |
| Receivables | $0 | $0 | $3.0K | $0 | $2.0K | $2.0K | $5.0K | $0 | $4.0K | $1.0K | $0 | $4.0K | $0 | $4.0K | $3M | $0 | |
| Prepaid Expense | $542.0K | $616.0K | $600.0K | $747.0K | $857.0K | $746.0K | $2M | $2M | $2M | $2M | $925.0K | $457.0K | $750.0K | $799.0K | $849.0K | $1M | |
| Current Assets | $666.0K | $970.0K | $2M | $3M | $4M | $1M | $3M | $4M | $5M | $6M | $13M | $19M | $38M | $54M | $56M | $61M | |
| PP&E (Net) | $74.0K | $82.0K | $91.0K | $97.0K | · | · | $0 | $0 | $0 | $0 | $6M | $7M | $8M | $8M | $9M | $10M | |
| PP&E (Gross) | · | · | $98.0K | · | · | · | $15.0K | · | · | · | · | · | · | $18M | · | · | |
| Accum. Depreciation | · | · | $7.0K | · | · | · | $15.0K | · | · | · | · | · | · | $10M | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $0 | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | |
| Total Assets | $2M | $2M | $3M | $4M | $5M | $2M | $3M | $4M | $5M | $6M | $19M | $28M | $49M | $65M | $67M | $74M | |
| Accounts Payable | $732.0K | $400.0K | $613.0K | $843.0K | $809.0K | $831.0K | $516.0K | $458.0K | $365.0K | $597.0K | $1M | $1M | $1M | $1M | $2M | $474.0K | |
| Accrued Liabilities | $132.0K | $195.0K | $200.0K | $78.0K | $265.0K | $231.0K | $176.0K | $368.0K | $542.0K | $643.0K | $3M | $3M | $4M | $5M | $8M | $6M | |
| Current Liabilities | $864.0K | $595.0K | $813.0K | $921.0K | $1M | $1M | $692.0K | $826.0K | $907.0K | $1M | $5M | $5M | $17M | $24M | $33M | $27M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $28.0K | $28.0K | $28.0K | $28.0K | |
| Total Liabilities | $864.0K | $595.0K | $813.0K | $921.0K | $1M | $1M | $692.0K | $826.0K | $907.0K | $1M | $6M | $6M | $19M | $26M | $35M | $34M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $17M | $23M | $25M | |
| Total Debt | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $11M | · | $23M | $25M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $16.0K | $241.0K | $241.0K | $241.0K | $16.0K | $216.0K | $216.0K | |
| Retained Earnings | $-927M | $-926M | $-925M | $-924M | $-923M | $-922M | $-920M | $-920M | $-919M | $-917M | $-908M | $-899M | $-891M | $-881M | $-871M | $-863M | |
| Stockholders' Equity | $652.0K | $1M | $2M | $3M | $4M | $1M | $2M | $3M | $4M | $5M | $14M | $22M | $30M | $39M | $32M | $40M | |
| Liabilities + Equity | $2M | $2M | $3M | $4M | $5M | $2M | $3M | $4M | $5M | $6M | $19M | $28M | $49M | $65M | $67M | $74M | |
| Shares Outstanding | 2,486,140 | 2,378,383 | 2,349,480 | 2,205,846 | 2,074,746 | 1,601,252 | 1,601,252 | 1,601,252 | 1,601,252 | 16,012,522 | 240,627,055 | 240,627,055 | 240,627,055 | 16,027,384 | 216,182,042 | 216,174,542 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $246.0K | $141.0K | $243.0K | $301.0K | $184.0K | $68.0K | $82.0K | $80.0K | $101.0K | $172.0K | $726.0K | $914.0K | $910.0K | $877.0K | $808.0K | $990.0K | |
| Restructuring | · | · | · | · | · | · | · | $0 | · | · | $419.0K | · | · | $0 | $0 | · | |
| Operating Cash Flow | $-300.0K | $-1M | $-552.0K | $-844.0K | $-701.0K | $-772.0K | $-592.0K | $-781.0K | $-2M | $-2M | $-6M | $-7M | $-9M | $-7M | $-6M | $-8M | |
| CapEx | · | · | $1.0K | · | · | · | $0 | $0 | $0 | $0 | $1.0K | $135.0K | $61.0K | $116.0K | $14.0K | $57.0K | |
| Investing Cash Flow | · | · | $-1.0K | · | · | · | $0 | $0 | $0 | $0 | $1.0K | $-135.0K | $-23.0K | $-93.0K | $-14.0K | $-57.0K | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | $-6M | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $92.0K | $15M | $0 | $0 | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | $92.0K | · | · | · | |
| Financing Cash Flow | · | · | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $-12M | $-6M | $8M | $-2M | $0 | |
| Net Change in Cash | $-230.0K | $-1M | $-553.0K | $-941.0K | $3M | $-772.0K | $-592.0K | $-781.0K | $-2M | $-2M | $-6M | $-19M | $-16M | $1M | $-8M | $-8M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-2M | · | · | $-9M | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -54600.0% | · | · | -29150.0% | -174200.0% | · | -199550.0% | · | · | -283.9% | · | |
| Net Margin | · | · | · | · | · | -53650.0% | · | · | -28225.0% | -168200.0% | · | -219325.0% | · | · | -304.1% | · | |
| EBITDA Margin | · | · | · | · | · | -54600.0% | · | · | -29150.0% | -174200.0% | · | -199550.0% | · | · | -283.9% | · | |
| ROA | -30.5% | -50.3% | · | -31.9% | -22.3% | -26.3% | · | -9.8% | -6.9% | -6.2% | -19.5% | -17.2% | -15.0% | · | -9.8% | -11.0% | |
| ROE | -44.1% | -85.8% | · | -41.9% | -28.3% | -36.6% | · | -13.6% | -8.9% | -9.8% | -36.8% | -28.4% | -25.6% | · | -17.6% | -15.5% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.6 | · | 2.9 | 3.5 | 1.0 | · | 4.3 | 5.2 | 4.9 | 2.8 | 3.7 | 2.2 | · | 1.7 | 2.3 | |
| Quick Ratio | 0.1 | 0.6 | · | 2.1 | 2.7 | 0.3 | · | 2.0 | 2.7 | 3.3 | 2.6 | 3.6 | 1.4 | · | 1.2 | 2.2 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.4 | · | 0.7 | 0.6 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | · | 0.0 | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -7.5 | -11.3 | · | -9.8 | -12.5 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | 0.0 | · | |
| Receivables Turnover | 0.0 | 0.0 | · | · | 0.0 | 1.3 | · | · | 1.0 | 2.0 | 0.0 | 2.0 | · | · | 1.3 | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.26 | $0.54 | · | $1.27 | $1.76 | $0.66 | · | $1.70 | $2.35 | $0.30 | $0.06 | $0.09 | $0.12 | · | $0.15 | $0.19 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | · | $0.01 | · | |
| Cash Flow / Share | · | $-0.53 | · | · | · | $-0.48 | · | · | · | $-0.12 | · | · | $-0.04 | · | · | · | |
| Cash / Share | $0.05 | $0.15 | · | $0.88 | $1.39 | $0.20 | · | $1.05 | $1.54 | $0.26 | $0.05 | $0.08 | $0.10 | · | $0.17 | $0.28 | |
| EPS (TTM) | $-1.90 | $-2.12 | · | $-2.31 | $-2.46 | $-2.54 | · | · | · | · | $-13.89 | $-8.63 | $-3.19 | · | $-0.20 | $-0.27 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.0K | $3.0K | · | $7.0K | $7.0K | $11.0K | · | · | · | · | $15.0K | $3M | $3M | · | · | · | |
| Net Income TTM | $-4M | $-4M | · | $-4M | $-4M | $-4M | · | $19M | $11M | $4M | $-36M | $-37M | $-38M | · | $-40M | $-54M | |
| Market Cap | $6M | $7M | · | $5M | $10M | $2M | · | $5M | $11M | $290M | $4.69B | $18.41B | $22.74B | · | $55.77B | $40.21B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | $286M | $4.68B | $18.39B | $22.73B | · | $55.76B | $40.17B | |
| P/E | -1.2 | -1.3 | · | -1.0 | -2.0 | -0.6 | · | · | · | · | -1.4 | -8.9 | -29.6 | · | -1290.0 | -688.9 | |
| P/S | 1872.9 | 2267.4 | · | 759.4 | 1437.5 | 214.0 | · | · | · | · | 312815.2 | 6291.2 | 7782.1 | · | · | · | |
| P/B | 8.6 | 5.3 | · | 1.9 | 2.7 | 2.2 | · | 1.9 | 3.0 | 60.4 | 337.6 | 850.3 | 770.6 | · | 1736.8 | 1000.7 | |
| P / Tangible Book | 8.6 | 5.3 | · | 1.9 | 2.7 | 2.2 | · | 1.9 | 3.0 | 60.4 | 337.6 | 850.3 | 770.6 | · | 1736.8 | 1000.7 | |
| P / Cash Flow | · | -6.6 | · | · | · | -3.0 | · | · | · | -151.2 | · | · | -2424.0 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | 312018.9 | 6284.9 | 7777.8 | · | · | · | |
| Earnings Yield | -84.1% | -74.1% | · | -95.9% | -50.7% | -172.8% | · | · | · | · | -71.2% | -11.3% | -3.4% | · | -0.08% | -0.15% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $5.0K | $10.0K | $5.0K | $3M | $398.0K |
| Faaliyet Kâr Marjı % | · | · | -685340.0% | -1201.4% | -19484.7% |
| Net Gelir | $-4M | $-5M | $-5M | $-38M | $-79M |
| Seyreltilmiş Hisse Başı Kâr | $-2.20 | $-2.92 | $-21.97 | $-2.61 | $-0.37 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | · | 0.0 | 0.4 | 0.4 |
| Cari Oran | · | · | 4.2 | 2.2 | 4.9 |
| Cari Oran | · | · | 3.1 | 1.6 | 4.8 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | · | $-30M | $-29M | $-65M |
Kurumsal Sahipler (13F) 33 dosya · $302K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
33
Tutulan Değer
$302K
Yeni pozisyonlar
6
Çıkan pozisyonlar
4
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 6 (0 önceki Ç'ye göre) | 4 (+2 önceki Ç'ye göre) | 6 (0 önceki Ç'ye göre) | 3 (-1 önceki Ç'ye göre) | -36K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $97.096 | 30.061 | 32,12% | Hisse senetleri |
| BlackRock, Inc. | $48.258 | 21.353 | 15,96% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $43.753 | 19.356 | 14,47% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $35.023 | 15.497 | 11,59% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $31.782 | 14.063 | 10,51% | Hisse senetleri |
| CITADEL ADVISORS LLC | $26.826 | 11.870 | 8,87% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $3.907 | 1.731 | 1,29% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $3.663 | 1.621 | 1,21% | Hisse senetleri |
| Arax Advisory Partners | $2.749 | 1.216 | 0,91% | Hisse senetleri |
| UBS Group AG | $2.242 | 992 | 0,74% | Hisse senetleri |
| MORGAN STANLEY | $1.889 | 836 | 0,62% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $1.132 | 501 | 0,37% | Hisse senetleri |
| ROYAL BANK OF CANADA | $1.000 | 375 | 0,33% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $877 | 388 | 0,29% | Hisse senetleri |
| CIBC Private Wealth Group LLC | $723 | 300 | 0,24% | Hisse senetleri |
| Blue Trust, Inc. | $305 | 135 | 0,10% | Hisse senetleri |
| Steward Partners Investment Advisory, LLC | $253 | 112 | 0,08% | Hisse senetleri |
| Federation des caisses Desjardins du Quebec | $158 | 70 | 0,05% | Hisse senetleri |
| BOKF, NA | $149 | 66 | 0,05% | Hisse senetleri |
| Axiom Investment Management LLC | $104 | 46 | 0,03% | Hisse senetleri |
| Key Financial Inc | $54 | 24 | 0,02% | Hisse senetleri |
| SIGNATUREFD, LLC | $52 | 23 | 0,02% | Hisse senetleri |
| NFSG Corp | $47 | 21 | 0,02% | Hisse senetleri |
| LANARK FINANCIAL, INC. | $45 | 20 | 0,01% | Hisse senetleri |
| AdvisorNet Financial, Inc | $43 | 19 | 0,01% | Hisse senetleri |
| BARCLAYS PLC | $34 | 15 | 0,01% | Hisse senetleri |
| Sunbelt Securities, Inc. | $29 | 10 | 0,01% | Hisse senetleri |
| Inspire Investing, LLC | $25 | 9 | 0,01% | Hisse senetleri |
| WEST PACES ADVISORS INC. | $23 | 10 | 0,01% | Hisse senetleri |
| CWM, LLC | $23 | 8 | 0,01% | Hisse senetleri |
| IFG Advisory, LLC | $14 | 6 | 0,00% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $14 | 6 | 0,00% | Hisse senetleri |
| Tidemark, LLC | $5 | 2 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 11 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Price Adrian, Chris Butterworth, Richard Jones, Edward Jones, Gareth Downing, Richard Kotey, Chris Cole, Arif Chaudrey, Emma Babb, Colin Craig, John Nicholls, Carl Ware, Andrew Turner, Matthew Robbins, Phillip James Stead, Stephen Hennessy, Greg Arnold, Michelle Douglas, HexagonONE Ltd, Alimenta Holding Limited, Krakatau Holding Limited ×3 başvurular | 05 Mart 2026 | 8,60% | Değişiklik | Yönetim kurulu kampanyası | SEC |
| Chris Butterworth, Richard Jones, Edward Jones, Gareth Downing, Richard Kotey, Chris Cole, Arif Chaudrey, Emma Babb, Colin Craig, John Nicholls, Carl Ware, Andrew Turner, Matthew Robbins, Phillip James Stead, Stephen Hennessy, Greg Arnold, Michelle Douglas, Price Adrian ×2 başvurular | 31 Ekim 2025 | 8,60% | Değişiklik | · | SEC |
| PMGC CAPITAL LLC, PMGC Holdings Inc. ×2 başvurular | 05 Eylül 2025 | 0,00% | Değişiklik | · | SEC |
| WaterMill Asset Management Corp., Postma Robert W | 01 Temmuz 2025 | 9,00% | İlk başvuru | · | SEC |
| RANDAL J. KIRK ×8 başvurular | 12 Aralık 2018 | · | İlk başvuru | · | SEC |
| 15 Ekim 2018 | · | İlk başvuru | · | SEC | |
| 06 Temmuz 2016 | · | İlk başvuru | · | SEC | |
| RANDAL KIRK | 09 Haziran 2015 | · | İlk başvuru | · | SEC |
| Millennium Partners, L.P., Millenco LLC, Millennium Management LLC, Israel A. Englander ×3 başvurular | 18 Haziran 2009 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 27 Eylül 2005 | · | İlk başvuru | · | SEC |
| Lindsay A. Rosenwald, M.D. | 23 Eylül 2005 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 46 içeriden öğrenenler · 22 yöneticiler · 26 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Dale Curtis Hogue Jr. | Chief Executive Officer, Interim | 29 Mart 2025 A | · | 0 | 0 | $0 |
| Kevin S. Boyle Sr. | Chief Executive Officer | 01 Eylül 2023 S | 798.236 | 0 | 0 | $0 |
| Laurence James Neil Cooper | President and CEO | 04 Ocak 2021 S | 1.799.280 | 0 | 0 | $0 |
| Jonathan Lewis | CEO | 31 Aralık 2014 A | 744.145 | 0 | 0 | $0 |
| Sath Shukla | EVP, Chief Financial Officer | 29 Ocak 2020 A | 80.500 | 0 | 0 | $0 |
| Jason Amello | Executive Vice President & CFO | 08 Mayıs 2013 F | 22.377 | 0 | 0 | $0 |
| David M Mauney MD | President | 29 Ocak 2020 A | 275.778 | 0 | 0 | $0 |
| Hagop Youssoufian | President of R&D and CMO | 31 Aralık 2012 A | 92.721 | 0 | 0 | $0 |
| Richard E Bagley | President, COO & Treasurer | 31 Aralık 2011 F | 211.239 | 0 | 0 | $0 |
| Caesar J Belbel | COO, CLO, and Secretary | 31 Aralık 2017 F | 207.434 | 0 | 0 | $0 |
| Ferdinand Groenewald | Vice President of Finance | 18 Ağustos 2025 A | 10.775 | 0 | 0 | $0 |
| Melinda Lackey | Legal & Administration | 29 Mart 2025 A | · | 0 | 0 | $0 |
| Abhishek K Srivastava | Vice President, Technical Operations | 15 Mart 2023 A | · | 0 | 0 | $0 |
| Drew Deniger | Vice President, Research and Development | 15 Mart 2023 A | · | 0 | 0 | $0 |
| Michael Wong | Vice President, Finance | 15 Mart 2023 A | · | 0 | 0 | $0 |
| Eleanor De Groot | EVP, Operations | 30 Mart 2022 A | 237.106 | 0 | 0 | $0 |
| Raffaele Baffa | Chief Medical Officer | 17 Mayıs 2021 A | 280.645 | 0 | 0 | $0 |
| Jill Buck | EVP, GM Gene Therapy | 04 Mart 2021 A | 231.016 | 0 | 0 | $0 |
| Robert Hadfield | Chief Legal Officer and Sec. | 04 Mart 2021 A | 176.819 | 0 | 0 | $0 |
| Kevin G Lafond | SVP, Treasurer & CAO | 08 Ocak 2021 S | 63.965 | 0 | 0 | $0 |
| Francois Lebel | Executive Vice President R&D | 31 Aralık 2017 F | 200.566 | 0 | 0 | $0 |
| Robert Peter Gale | Senior V.P. of Research | 26 Nisan 2006 A | · | 0 | 0 | $0 |
| Michael Allen Jerman | Yönetim kurulu üyesi | 23 Temmuz 2026 A | 23.759 | 0 | 0 | $0 |
| Jaime Vieser | Yönetim kurulu üyesi | 23 Temmuz 2026 A | 47.642 | 0 | 0 | $0 |
| Postma Robert W | Yönetim kurulu üyesi | 23 Temmuz 2026 A | 58.609 | 0 | 0 | $0 |
| Robert Hofmeister | Yönetim kurulu üyesi | 06 Haziran 2024 A | · | 0 | 0 | $0 |
| James Huang | Yönetim kurulu üyesi | 06 Haziran 2023 A | 188.333 | 0 | 0 | $0 |
| Mary Thistle | Yönetim kurulu üyesi | 06 Haziran 2023 A | 45.000 | 0 | 0 | $0 |
| Christopher Bowden | Yönetim kurulu üyesi | 22 Haziran 2022 A | 44.167 | 0 | 0 | $0 |
| Heidi Hagen | Yönetim kurulu üyesi | 02 Eylül 2021 P | 145.889 | 0 | 0 | $0 |
| Kevin J Buchi | Yönetim kurulu üyesi | 04 Mart 2021 A | 4.167 | 0 | 0 | $0 |
| Scott Braunstein | Yönetim kurulu üyesi | 31 Aralık 2019 A | 31.780 | 0 | 0 | $0 |
| Douglas W. Pagan | Yönetim kurulu üyesi | 31 Aralık 2019 A | 35.943 | 0 | 0 | $0 |
| Elan Ezickson | Yönetim kurulu üyesi | 31 Aralık 2019 F | 71.887 | 0 | 0 | $0 |
| Scott Tarriff | Yönetim kurulu üyesi | 31 Aralık 2019 A | 4.186 | 0 | 0 | $0 |
| James Anthony Cannon | Yönetim kurulu üyesi | 07 Mayıs 2019 M | 398.050 | 0 | 0 | $0 |
| Murray Brennan | Yönetim kurulu üyesi | 30 Aralık 2017 F | 72.620 | 0 | 0 | $0 |
| Wyche Fowler | Yönetim kurulu üyesi | 30 Aralık 2017 F | 156.446 | 0 | 0 | $0 |
| Michael Weiser | Yönetim kurulu üyesi | 30 Aralık 2017 F | 224.282 | 0 | 0 | $0 |
| RANDAL J. KIRK | Yönetim kurulu üyesi | 31 Ağustos 2016 J | 122.309 | 0 | 0 | $0 |
| Timothy Mcinerney | Yönetim kurulu üyesi | 31 Aralık 2014 F | 372.120 | 0 | 0 | $0 |
| George B Abercrombie | Yönetim kurulu üyesi | 05 Nisan 2010 A | 25.000 | 0 | 0 | $0 |
| Gary S Fragin | Yönetim kurulu üyesi | 31 Mart 2010 A | 67.500 | 0 | 0 | $0 |
| ESSEX WOODLANDS HEALTH VENTURES FUND VI L P | 10% sahip | 08 Aralık 2009 P | 2.371.642 | 0 | 0 | $0 |
| Lindsay A. Rosenwald, M.D. | 10% sahip | 03 Mayıs 2006 J | · | 0 | 0 | $0 |
| Holger Weis | · | 06 Ağustos 2026 A | 25.483 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 1 ETF tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 14.063 SH | 19 Ağustos 2026 | Günlük |
TCRT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 6 analist
SAT
0 0,0%
Güçlü Al
0 0,0%
Al
3 50,0%
Tut
1 16,7%
Sat
2 33,3%
Güçlü Sat
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 14, 2026